Trial Profile
PHASE II STUDY OF NEOADJUVANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 May 2011
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Rectal cancer
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms XELOXART
- 25 May 2011 New trial record